Table 1.
Clinical characteristics of the cohort
| Variable | Entire cohort (n = 25) |
|---|---|
| Age (years) | 63 (59–66) |
| Women | 15 (60%) |
| Caucasian | 16 (64%) |
| African-American | 9 (36%) |
| Cancer type | |
| Lung | 15 (60%) |
| Breast | 10 (40%) |
| Time since cancer diagnosis (years) | 2.4 (0.3–8.6) |
| Time since completion of chemotherapy (years) | 1.5 (0.1–7.4) |
| Prior chemotherapy | 21 (84%) |
| Anthracycline-based chemotherapy | 6 (24%) |
| Time since completion of radiotherapy (years) | 1.8 (0.1–8.2) |
| Cancer stage | Breast cancer n = 10 | Lung cancer n = 15 |
|---|---|---|
| IA | 1 (4%) | 1 (4%) |
| IB | 1 (4%) | |
| II | 1 (4%) | |
| IIA | 1 (4%) | |
| IIB | 1 (4%) | |
| IIIA | 3 (12%) | 10 (40%) |
| IIIB | 2 (8%) | 3 (12%) |
| IIIC | 1 (4%) |
Data are listed as median and (absolute range) or n (%).